Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis-Reference-Cited by-同舟云学术

Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis

Published:2013-03 Issue:5 Volume:49 Page:1027-1031
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Montemurro M.,Gelderblom H.,Bitz U.,Schütte J.,Blay J.Y.,Joensuu H.,Trent J.,Bauer S.,Rutkowski P.,Duffaud F.,Pink D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Treatment of gastrointestinal stromal tumor after imatinib and sunitinib;Montemurro;Curr Opin Oncol,2011

2. Demetri GD, Le Cesne A, Von Mehren M, et al. Final results from a phase III study of IPI-504 (retaspimycin hydrochloride) versus placebo in patients (pts) with gastrointestinal stromal tumors (GIST) following failure of kinase inhibitor therapies. In: ASCO gastrointestinal cancers symposium 2010, San Francisco, USA; 2010 [Abstract 64].

3. A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors;Schoffski;Ann Oncol,2010

4. Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I–II study by the Spanish Group for Research on Sarcomas;Maurel;Cancer,2010

5. Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib;Montemurro;Eur J Cancer,2009

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors;International Journal of Molecular Sciences;2023-03-23

2. Hand-Foot Skin Reaction by Sorafenib;Journal of the Turkish Academy of Dermatology;2022-12-01

3. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022;Journal of the National Comprehensive Cancer Network;2022-11

4. Soft Tissue Sarcomas;Holland‐Frei Cancer Medicine;2022-10-21

5. Gastrointestinal Stromal Tumors: 10-Year Experience in Cancer Center—The Ottawa Hospital (TOH);Current Oncology;2022-09-29